Di Pasquale E, Monteau R, Hilaire G
Biologie des Rythmes et du Développement, URA CNRS 1832, Faculté des Sciences et Techniques St Jérôme, Marseille, France.
Brain Res Dev Brain Res. 1994 Jul 15;80(1-2):222-32. doi: 10.1016/0165-3806(94)90107-4.
The aim of the present work was to know whether the excitatory modulation of the central respiratory rhythm generator by serotonin (5-HT) previously found to occur in the newborn rat, is already functional during the fetal life. Experiments were performed at embryonic day 18 (D18) and 20-21 (D20-21; full-term day 21) on the fetal rat brainstem-spinal cord preparation in which the ability to generate central respiratory activity in vitro persists. Replacing the normal medium which bathed the preparation by a medium containing 5-HT increased the respiratory frequency (RF) within 2-3 min in a dose-dependent manner in both D18 and D20-21 fetuses but the effect was particularly drastic at D18. Applying a medium containing the 5-HT antagonist, methysergide, to block the effect of endogenous 5-HT, if any, reduced the RF within 2-3 min and the reduction was especially drastic at D18 where respiratory arrests occurred for several minutes in most of the experiments. Applying a medium containing either the 5-HT reuptake inhibitor fluoxetine to potentiate the effect of endogenous 5-HT or the 5-HT precursor, L-tryptophan, to activate 5-HT biosynthesis mechanisms, increased the RF. To define the type of 5-HT receptors involved in the modulation of the RF, experiments were conducted with specific 5-HT agonists and antagonists. Both 5-HT1 (8-OH-DPAT, buspirone) and 5-HT2 agonists (DOI, alpha-methyl-5-HT) increased the RF but only the 5-HT1A agonist 8-OH-DPAT was efficient at submicromolar concentrations. Applying the 5-HT1A antagonist NAN-190 alone decreased the RF and even elicited respiratory arrests while the 5-HT2 antagonist ketanserin was inefficient. NAN-190 pre-treatment blocked the increase in the RF due to 8-OH-DPAT and 5-HT. Taken as a whole these results clearly indicate that endogenous 5-HT exerts an excitatory modulation on the respiratory rhythm generator via activation of medullary 5-HT1A receptors well before birth, as soon as D18 where the modulation is particularly potent.
本研究的目的是了解先前在新生大鼠中发现的血清素(5-羟色胺,5-HT)对中枢呼吸节律发生器的兴奋性调节在胎儿期是否已经发挥作用。实验在胚胎第18天(D18)和第20 - 21天(D20 - 21;足月为第21天)对胎鼠脑干 - 脊髓标本进行,该标本在体外仍具有产生中枢呼吸活动的能力。用含5-HT的培养基替换浸泡标本的正常培养基,在D18和D20 - 21胎鼠中,均在2 - 3分钟内以剂量依赖性方式增加呼吸频率(RF),但在D18时这种效应尤为显著。应用含5-HT拮抗剂美西麦角的培养基来阻断内源性5-HT(如果有的话)的作用,在2 - 3分钟内降低了RF,在D18时降低尤为显著,在大多数实验中呼吸会停止几分钟。应用含5-HT再摄取抑制剂氟西汀以增强内源性5-HT的作用,或应用5-HT前体L-色氨酸以激活5-HT生物合成机制,均可增加RF。为了确定参与调节RF的5-HT受体类型,使用了特异性的5-HT激动剂和拮抗剂进行实验。5-HT1(8-羟基二丙胺基四氢萘,丁螺环酮)和5-HT2激动剂(DOI,α-甲基-5-HT)均增加了RF,但只有5-HT1A激动剂8-羟基二丙胺基四氢萘在亚微摩尔浓度时有效。单独应用5-HT1A拮抗剂NAN-190可降低RF,甚至引发呼吸停止,而5-HT2拮抗剂酮色林则无效。NAN-190预处理可阻断由8-羟基二丙胺基四氢萘和5-HT引起的RF增加。总体而言,这些结果清楚地表明,内源性5-HT早在出生前,即D18时就通过激活延髓5-HT1A受体对呼吸节律发生器发挥兴奋性调节作用,且在D18时这种调节作用尤为强大。